Back to UCLA Health

Department of Medicine

A community resource for faculty and staff


  • Home
  • Message from the Chair
  • Announcements
  • Publications
  • Events
  • Strategic Planning Initiative
  • Contact Us
  1. < Hematology/Oncology

Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution study

By afschroeder • May 29, 2026

LeVee A, Santos B, Wong M, Ruel N, Schmolze D, Kang I, Tsai K, Mortimer J, McArthur H. Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution study. Breast Cancer Res Treat. 2026 May 28;217(2):38. doi: 10.1007/s10549-026-07984-8. PMID: 42207343.


Tags: Hematology/Oncology, immunotherapy, Neoadjuvant chemotherapy, pathologic complete response, pembrolizumab, Publications, triple-negative breast cancer

Related Posts

OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML

Borate UM, Huang Y, Lin TL, Handa S, Swords R, Lachowiez CA, Traer E, Stock W, Odenike O, Patel AA, Baer MR, Duong VH, Stein[...]

Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004

Wierda WG, Dorritie KA, Gauthier J, Nath R, Kipps TJ, Riedell PA, Eradat HA, Kenderian SS, Kharfan-Dabaja MA, Shah NN, Solomon SR, Stephens DM, Ermann[...]

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis

Ronald Reagan UCLA Medical Center Best Hospitals Honor Roll
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
  • HIPAA Notice
  • Privacy Notice
  • Nondiscrimination
  • Report an Incident
  • Accessibility
  • © 2026 UCLA Health
© 2026 UCLA Health